Dynavax Technologies Corporation (DVAX): Price and Financial Metrics

Dynavax Technologies Corporation (DVAX): $11.80

0.46 (+4.06%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

B

Add DVAX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#41 of 362

in industry

DVAX Price/Volume Stats

Current price $11.80 52-week high $15.15
Prev. close $11.34 52-week low $10.06
Day low $11.25 Volume 9,289,900
Day high $11.86 Avg. volume 2,044,697
50-day MA $12.35 Dividend yield N/A
200-day MA $13.55 Market Cap 1.54B

DVAX Stock Price Chart Interactive Chart >


Dynavax Technologies Corporation (DVAX) Company Bio


Dynavax Technologies Corporation is a clinical-stage biopharmaceutical company, using TLR biology to discover and develop novel vaccines and therapeutics in the areas of infectious and inflammatory diseases and oncology. The company was founded in 1996 and is based in Berkeley, California.


DVAX Latest News Stream


Event/Time News Detail
Loading, please wait...

DVAX Latest Social Stream


Loading social stream, please wait...

View Full DVAX Social Stream

Latest DVAX News From Around the Web

Below are the latest news stories about DYNAVAX TECHNOLOGIES CORP that investors may wish to consider to help them evaluate DVAX as an investment opportunity.

Mirum (MIRM) Down on Failure of Mid-Stage Study on Livmarli

Mirum (MIRM) faces a setback in its efforts to expand its lead drug Livmarli's label for the indication of biliary atresia in patients who have undergone a Kasai surgery.

Yahoo | December 19, 2023

NextCure (NXTC) Down on Shelving Plans to Develop Candidate

NextCure (NXTC) plans to focus on developing LNCB74 and stop the development of NC762 to conserve cash. The company's shares decline on the same.

Yahoo | December 15, 2023

Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year?

Here is how Aquestive Therapeutics (AQST) and Dynavax Technologies (DVAX) have performed compared to their sector so far this year.

Yahoo | December 13, 2023

Can Dynavax Technologies (DVAX) Climb 91.59% to Reach the Level Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 91.6% in Dynavax Technologies (DVAX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Yahoo | December 5, 2023

Kiniksa Pharmaceuticals (KNSA) Up 14.7% YTD: Here's How

Kiniksa Pharmaceuticals (KNSA) enjoys a good run in the year on the back of solid revenue growth and pipeline updates.

Yahoo | November 24, 2023

Read More 'DVAX' Stories Here

DVAX Price Returns

1-mo -3.99%
3-mo -16.78%
6-mo -17.42%
1-year 7.08%
3-year 23.69%
5-year 81.26%
YTD -15.59%
2023 31.39%
2022 -24.38%
2021 216.18%
2020 -22.20%
2019 -37.49%

Continue Researching DVAX

Want to see what other sources are saying about Dynavax Technologies Corp's financials and stock price? Try the links below:

Dynavax Technologies Corp (DVAX) Stock Price | Nasdaq
Dynavax Technologies Corp (DVAX) Stock Quote, History and News - Yahoo Finance
Dynavax Technologies Corp (DVAX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!